• Polygodial as a TRPA1 Channel Activator: Protocols & Innovat

  2026-06-25

  Polygodial empowers researchers to precisely activate TRPA1 channels in sensory neuron and epithelial models, unraveling Ca2+/NFAT-driven inflammatory pathways. Its rapid DMSO solubility and robust signal modulation make it the compound of choice for reproducible ion channel research and neurophysiology workflows.

• TPPU and sEH Inhibition: Unraveling the Liver-Bone Axis in R

  2026-06-24

  Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, enables new frontiers in bone metabolism and chronic inflammation research by targeting the liver-bone signaling axis. This in-depth analysis reveals mechanistic insights and practical applications distinct from existing content.

• VE-822 ATR Inhibitor: Selective DNA Damage Response Modulati

  2026-06-23

  VE-822 is a potent ATR inhibitor with an IC50 of 0.019 μM, enabling selective DNA damage response inhibition in cancer models. Its unique mechanism sensitizes pancreatic ductal adenocarcinoma (PDAC) cells to chemoradiotherapy while sparing normal tissue. This dossier details VE-822’s molecular action, validated research protocols, and practical limitations for advanced cancer research.

• 3-Bromopyruvate and Cetuximab: Overcoming CRC Resistance via

  2026-06-23

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab induces autophagy-dependent ferroptosis and apoptosis in colorectal cancer cells, effectively overcoming both intrinsic and acquired drug resistance. The findings highlight the mechanistic restoration of FOXO3a signaling and suggest new strategies for targeting refractory metastatic colorectal cancer.

• Exercise-Induced Extracellular Vesicles Enhance Amyloid Clea

  2026-06-22

  This study uncovers how swimming exercise increases skeletal muscle-derived extracellular vesicles (SKM-EVs), which are taken up by microglia to enhance amyloid-beta plaque clearance in Alzheimer’s disease (AD) mouse models. The findings reveal a novel mechanism linking peripheral muscle activity to central amyloid pathology, highlighting extracellular vesicles as potential therapeutic mediators for cognitive dysfunction in AD.

• Cy5 NHS ester(Et): Technical Guide for Biomolecule Labeling

  2026-06-22

  Cy5 NHS ester(Et) addresses the need for stable and high-purity fluorescent labeling of primary amines in proteins and other biomolecules, particularly in workflows such as immunofluorescence staining and flow cytometry. It should be avoided in ethanol-based protocols and for applications requiring long-term storage of dye solutions, as per product stability guidelines.

• PRMT5-Regulated Splicing Reveals Glutamine Metabolism Vulner

  2026-06-21

  This study uncovers a spliceosomal and metabolic vulnerability in MYCN-amplified neuroblastoma, showing that PRMT5 inhibition disrupts both RNA splicing and glutamine metabolism. The findings establish the epitranscriptome and metabolic pathways as convergent nodes for targeted intervention, with implications for preclinical cancer metabolism research workflows.

• Modified Ethanol Injection Enhances mRNA Lipoplex Delivery E

  2026-06-20

  Tang et al. introduce a modified ethanol injection (MEI) technique to efficiently generate mRNA lipoplexes for delivery in vitro and in vivo. Their findings highlight improved protein expression and immunogenicity, offering a streamlined approach to mRNA delivery that is relevant for vaccine and therapeutic applications.

• Practical Guide: Cy7 NHS Ester for Protein Labeling and Imag

  2026-06-19

  Cy7 NHS ester offers a sulfonated, water-soluble near-infrared dye solution for labeling amino groups in proteins and peptides, supporting non-destructive in vivo and in vitro imaging workflows. It is best suited for applications requiring minimal protein denaturation and high signal retention, but not for workflows needing long-term dye solution storage or targets lacking accessible amino groups.

• Magnetic CSNP-Exosome Hydrogel Restores Bladder Function via

  2026-06-19

  This study demonstrates that a magnetic chitosan nanoparticle-exosome hydrogel enhances bladder function in diabetic bladder dysfunction by activating the FAK-p38 MAPK-GATA4 signaling axis in adipose-derived mesenchymal stromal cells. The findings offer mechanistic insight into regenerative strategies for chronic urological disease and highlight new avenues for targeted cell therapy.

• TRPV1 and TRPA1 Activation Drives TSLP in Nasal Epithelia

  2026-06-18

  This study delineates how TRPV1 and TRPA1 channel activation promotes TSLP and inflammatory cytokine production in nasal epithelial cells via the Ca2+/NFAT pathway. These findings clarify mechanistic links between environmental stimuli, sensory ion channel activity, and upper airway inflammation, informing translational research on nonallergic rhinitis and related conditions.

• Vitamin C Inhibits HEI-OC1 Cell Senescence via ROS/NF-κB Pat

  2026-06-18

  The 2024 study by Xu et al. demonstrates that vitamin C significantly ameliorates D-galactose-induced senescence in cochlear hair cell models by suppressing the ROS/NF-κB signaling axis. These findings highlight a mechanistic link between ascorbic acid, oxidative stress modulation, and potential strategies for delaying age-related hearing loss.

• O6-Benzylguanine: Applied MGMT Inhibition in Cancer Research

  2026-06-17

  O6-Benzylguanine delivers robust, reproducible MGMT inhibition for DNA repair studies and cancer chemotherapy research. This guide translates recent mechanistic breakthroughs and practical workflows into actionable protocols—empowering researchers to optimize alkylating agent sensitivity, troubleshoot resistance, and accelerate translational impact.

• In Vitro Drug Response Metrics: Advances in Cancer Evaluatio

  2026-06-17

  Schwartz’s dissertation introduces a critical comparison of relative and fractional viability metrics in in vitro cancer drug studies, revealing that these commonly conflated measures capture distinct aspects of drug action. The research highlights the importance of precisely characterizing both proliferative arrest and cell death to improve experimental rigor and translational relevance.

• Bacitracin (B1670): Practical Guide for Antibacterial Resear

  2026-06-16

  Bacitracin (B1670) is a peptide antibiotic formulated for laboratory workflows targeting bacterial cell wall and peptidoglycan synthesis disruption. It is suitable for antibacterial research involving both gram-positive and gram-negative bacteria, but is strictly not for diagnostic or medical use.

443 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page